Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

International Journal of Molecular Sciences, 2023
Plasma Proteomics Unveil Novel Immune Signatures and Biomarkers upon SARS-CoV-2 Infection

Urbiola-Salvador V., Lima de Souza S., Grešner P. et al.

Olink Explore 3072/384Infectious DiseasesPathophysiologyPlasma

Nature Medicine, 2023
Multiomic signatures of body mass index identify heterogeneous health phenotypes and responses to a lifestyle intervention

Watanabe K., Wilmanski T., Diener C. et al.

Olink Target 96Metabolic DiseasesPathophysiologyPatient StratificationPlasma

GeroScience, 2023
Plasma levels of neurology-related proteins are associated with cognitive performance in an older population with overweight/obesity and metabolic syndrome

Llaurador-Coll M., Rios S., García-Gavilán J. et al.

Olink Target 96NeurologyAgingPathophysiologyPatient StratificationPlasma

Biomedicines, 2023
Inflammatory Markers as Predictors of Shunt Dependency and Functional Outcome in Patients with Aneurysmal Subarachnoid Hemorrhage

Rostgaard N., Olsen M., Capion T. et al.

Olink Target 96NeurologyPatient StratificationCSF

Clinical Proteomics, 2023
Discovery of novel glioma serum biomarkers by proximity extension assay

Ghorbani A., Avery L., Sohaei D. et al.

Olink Explore 3072/384OncologyPatient StratificationPlasma

International Journal of Nephrology, 2023
Growth Differentiation Factor 15 and Risk of Death in Haemodialysis Patients

Calen C., Von Moos S., Cippà P. et al.

Olink Target 96NephrologyPatient StratificationPlasma

Clinical and Translational Allergy, 2023
Obese asthma phenotypes display distinct plasma biomarker profiles

Björkander S., Klevebro S., Hernandez‐Pacheco N. et al.

Olink Target 96Metabolic DiseasesImmunological & Inflammatory DiseasesPathophysiologyPatient StratificationPlasma

Inflammation, 2023
Inflammation Biomarker Response to Oral 2-Hydroxybenzylamine (2-HOBA) Acetate in Healthy Humans

Rathmacher J., Fuller J., Abumrad N. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma

Journal of Crohn's and Colitis, 2023
Serum Immune Profiling in Paediatric Crohn’s Disease Demonstrates Stronger Immune Modulation With First-Line Infliximab Than Conventional Therapy and Pre-Treatment Profiles Predict Clinical Response to Both Treatments

Jongsma M., Costes L., Tindemans I. et al.

Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationSerum

Scientific Reports, 2023
Evaluation of pre-processing methods for tear fluid proteomics using proximity extension assays

Vergouwen D., Schotting A., Endermann T. et al.

Olink Target 96OphthalmologyTechnical EvaluationTear Fluid

Translational Research, 2023
Deep next-generation proteomics and network analysis reveal systemic and tissue-specific patterns in Fabry disease

Tebani A., Barbey F., Dormond O. et al.

Olink Explore 3072/384Other Diseases & SyndromesPathophysiologyPatient StratificationPlasma

Journal of Veterinary Internal Medicine, 2023
Cerebrospinal fluid and serum proteomic profiles accurately distinguish neuroaxonal dystrophy from cervical vertebral compressive myelopathy in horses

Donnelly C., Johnson A., Reed S. et al.

Olink Explore 3072/384NeurologyPatient StratificationHorse CSFHorse Plasma

European Journal of Cell Biology, 2023
OxLDL sensitizes platelets for increased formation of extracellular vesicles capable of finetuning macrophage gene expression

Maaninka K., Neuvonen M., Kerkelä E. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyEV Lysate

International Journal of Molecular Sciences, 2023
Differential Effects of Iron Chelates vs. Iron Salts on Induction of Pro-Oncogenic Amphiregulin and Pro-Inflammatory COX-2 in Human Intestinal Adenocarcinoma Cell Lines

Tarczykowska A., Engström N., Dobermann D. et al.

Olink Target 96OncologyNutritional SciencePathophysiologyCell Lysate

eBioMedicine, 2023
Multi-omics analysis uncovers tumor ecosystem dynamics during neoadjuvant toripalimab plus nab-paclitaxel and S-1 for esophageal squamous cell carcinoma: a single-center, open-label, single-arm phase 2 trial

Zhang G., Yuan J., Pan C. et al.

Olink Target 96OncologyPathophysiologyPlasma

International Journal of Molecular Sciences, 2023
Saliva and Saliva Extracellular Vesicles for Biomarker Candidate Identification—Assay Development and Pilot Study in Amyotrophic Lateral Sclerosis

Sjoqvist S., Otake K.

Olink Target 96Wider Proteomics StudiesTechnical EvaluationEV LysateSaliva

JACC: Advances, 2023
Biomarkers and Coronary Microvascular Dysfunction in Women With Angina and No Obstructive Coronary Artery Disease

Prescott E., Bove K., Bechsgaard D. et al.

Olink Target 96CVDPatient StratificationPlasma

Journal of Investigative Dermatology, 2023
Staphylococcus Aureus and Streptococcus Pyogenes Induce Psoriasis-Related Transcriptomes Augmented by IL-17A and TNF-α

Miura S., Ichimura Y., Sela U. et al.

Olink Target 96Dermatological DiseasesPathophysiologyCell Culture Supernatant

International Journal of Molecular Sciences, 2023
Does the Use of the “Proseek® Multiplex Inflammation I Panel” Demonstrate a Difference in Local and Systemic Immune Responses in Endometriosis Patients with or without Deep-Infiltrating Lesions?

Perricos A., Husslein H., Kuessel L. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPatient StratificationPlasmaPeritoneal Fluid

Ocular Immunology and Inflammation, 2023
Non-Infectious Uveitis Secondary to Dupilumab Treatment in Atopic Dermatitis Patients Shows a Pro-Inflammatory Molecular Profile

Achten R., van Luijk C., Thijs J. et al.

Olink Target 96OphthalmologyDermatological DiseasesPathophysiologyAqueous Humor

3026 publications